Effects of 2-(substituted-sulfanyl)-3,5-dihydro-imidazole-4-one and 2-(substituted-sulfanyl)-1H-imidazole-4,5-dione derivatives on serum HDL-cholesterol

Bioorg Med Chem Lett. 2000 Aug 21;10(16):1791-4. doi: 10.1016/s0960-894x(00)00338-3.

Abstract

A series of 2-substituted sulfanyl-3,5-dihydro-imidazole-4-ones and 2-substituted sulfanyl-1H-imidazole-4,5-diones was prepared and shown to increase high density lipoprotein cholesterol over other lipid fractions. Compound 1f showed efficacy in additional animal models. The major metabolite of 1f was isolated and its synthesis is reported. The effects of the metabolite on the lipid profile in rats were investigated.

MeSH terms

  • Animals
  • Anticholesteremic Agents / administration & dosage
  • Anticholesteremic Agents / chemistry
  • Anticholesteremic Agents / pharmacology*
  • Cholesterol / administration & dosage
  • Cholesterol, HDL / blood*
  • Cholesterol, HDL / metabolism
  • Cholesterol, LDL / blood
  • Cholesterol, VLDL / blood
  • Cricetinae
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / chemical synthesis*
  • Imidazoles / chemistry
  • Imidazoles / pharmacology*
  • Lipoproteins / blood
  • Male
  • Microsomes, Liver / metabolism
  • Molecular Structure
  • Rats

Substances

  • Anticholesteremic Agents
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Imidazoles
  • Lipoproteins
  • Cholesterol